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Abstract
Background: Project MATCH was the largest and most expensive alcoholism treatment trial ever
conducted. The results were disappointing. There were essentially no patient-treatment matches,
and three very different treatments produced nearly identical outcomes. These results were
interpreted post hoc as evidence that all three treatments were quite effective. We re-analyzed the
data in order to estimate effectiveness in relation to quantity of treatment.
Methods: This was a secondary analysis of data from a multisite clinical trial of alcohol dependent
volunteers (N = 1726) who received outpatient psychosocial therapy. Analyses were confined to
the primary outcome variables, percent days abstinent (PDA) and drinks per drinking day (DDD).
Overall tests between treatment outcome and treatment quantity were conducted. Next, three
specific groups were highlighted. One group consisted of those who dropped out immediately; the
second were those who dropped out after receiving only one therapy session, and the third were
those who attended 12 therapy sessions.
Results: Overall, a median of only 3% of the drinking outcome at follow-up could be attributed to
treatment. However this effect appeared to be present at week one before most of the treatment
had been delivered. The zero treatment dropout group showed great improvement, achieving a
mean of 72 percent days abstinent at follow-up. Effect size estimates showed that two-thirds to
three-fourths of the improvement in the full treatment group was duplicated in the zero treatment
group. Outcomes for the one session treatment group were worse than for the zero treatment
group, suggesting a patient self selection effect. Nearly all the improvement in all groups had
occurred by week one. The full treatment group had improved in PDA by 62% at week one, and
the additional 11 therapy sessions added only another 4% improvement.
Conclusion: The results suggest that current psychosocial treatments for alcoholism are not
particularly effective. Untreated alcoholics in clinical trials show significant improvement. Most of
the improvement which is interpreted as treatment effect is not due to treatment. Part of the
remainder appears to be due to selection effects.
Background
A fundamental belief of addiction treatment is that ther-
apy is effective. Addiction counselors are encouraged to
use methods that have been shown to be effective in high
quality clinical trials [1]. Three of the best of those meth-
ods were selected for Project MATCH, a large multicenter
US trial designed to match the most effective treatment to
individual patient characteristics. The criteria used to
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select the three treatments used in MATCH included the
following: demonstrated clinical effectiveness; applicabil-
ity to existing treatment programs and client populations,
and distinctiveness from each other [2].
Project MATCH took great care to assure that the therapy
was of the highest quality. Therapy was manualized and
the three manuals [3-5] were organized into specific treat-
ment sessions. Cognitive Behavioral Therapy (CBT)
focused on handling thoughts about alcohol, dealing with
urges, refusing drinks, avoiding situations that might lead
to relapse, etc. Motivational Enhancement Therapy (MET)
provided structured feedback about alcohol-related prob-
lems, and attempted to motivate commitment to change,
to increase individual responsibility, and to enlist per-
sonal resources. Twelve Step Facilitation (TSF) was based
on principles of Alcoholics Anonymous and it introduced
the first three steps of AA and promoted active participa-
tion in AA. Therapists were required to have a Masters
degree or Certified Addiction Counselor degree, a com-
mitment to the particular therapeutic approach that they
would provide (i.e., CBT, MET, or TSF), and at least two
years experience. Therapist training was centralized at the
coordinating center using seminars, required two super-
vised training cases, and also included some ongoing
supervision of all sessions. Therapists taped their sessions
with clients, and the tapes were scored at the coordinating
center.
In some ways, the results of the MATCH clinical trial were
disappointing. At the time it was concluded, in the late
1990s, it was the one of the most expensive clinical trials
ever undertaken, costing 27 million dollars; it was con-
ducted by the most seasoned alcoholism professional
investigators, and it was designed to validate the top "cut-
ting-edge" findings which had accumulated the strongest
experimental support. Some 504 hypotheses were tested
[6]. The final results did not support the hypotheses.
There were essentially no matches between the therapeu-
tic treatments and the participants above the level of ran-
dom probability [6]. An analysis of the problem suggested
that too many Type I errors were being made in the alco-
holism literature [7]. Type I errors typically occur when an
inappropriately large number of statistical tests are
performed.
In announcing the disappointing MATCH results, the
director of the National Institute of Alcohol Abuse and
Alcoholism stated "All three treatments evaluated in
Project MATCH produced excellent overall outcomes" [8].
That position was given scientific weight most notably by
William Miller and colleagues in their paper "How effec-
tive is alcoholism treatment in the United States?" [9].
They suggested that treatment is extremely effective by
way of presenting the MATCH results, and results of other
large multi-site alcoholism trials. Table 1 shows outcome
data abstracted from that paper. In addition to MATCH,
the studies consisted of an analysis conducted by the Rand
Corporation of treatment programs around the U.S. [10],
a study at Veteran's Hospitals that compared disulfiram
(Antabuse) to placebo [11], a VA study comparing lithium
to placebo [12], a study on relapse [13], and a study com-
paring 12-step to cognitive-behavioral treatment [14].
Table 1 shows that the MATCH outcomes were very simi-
lar to the outcomes of the other studies.
The effectiveness of psychosocial therapy for alcoholism is
being challenged in a number of different ways. Evidence
is accumulating that extensive therapy may be no more
effective that brief intervention [1,15]. Brief interventions
are minimal types of therapies that can consist of simple
expressions of concern about drinking delivered by a MD
in a hospital trauma unit. There is a growing literature on
"natural recovery" showing that many, if not most, indi-
viduals with serious alcohol consumption problems are
able to recover without treatment [16]. A recently pub-
lished meta-analysis [17] reported a significant improve-
ment in untreated alcoholics enrolled in clinical trials.
And there have been a few published trials that have con-
cluded that therapy is not particularly effective [18,19].
The present study reports analyses of some overlooked
data from Project MATCH. The overall relationship
between treatment quantity (number of treatment ses-
sions attended) and drinking measures was analyzed.
Next, primary outcome data of participants who dropped
out of treatment before receiving any therapy was com-
pared to that of participants who attended each and every
session for the full 12 weeks of therapy. Additionally we
identified one anomalous group consisting of those par-
ticipants who attended only one session of therapy. The
data from this unusual group provides additional clues
that help in interpreting the findings.
Table 1: Alcoholism treatment 12 month outcome data cited by 
Miller to suggest that treatment is effective.
Multi-center trial Percent days abstinent Drinks per drinking day
Lithium/Placebo 83
Disulfiram/Placebo 84
Relapse prevention 85 5
MATCH 77 5
12 Step/Cognitive 8
Rand 5
Mean 82 6BMC Public Health 2005, 5:75 http://www.biomedcentral.com/1471-2458/5/75
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Methods
The MATCH Data set was made available to qualified
researchers after the study had been completed. As an
NIAAA committee member designing another large multi-
center funded alcoholism study, the senior author of this
study (RBC) obtained an official copy of the Project
MATCH Public Data Set (V1.0) from the Coordinating
Center in Farmington, Connecticut on August 24, 1998.
The trial was conducted with approval from the appropri-
ate ethics committees, with informed written consents,
and the procedure was in compliance the Helsinki Decla-
ration. This data set comprised some 256 variables on all
1726 participants in Project MATCH. Drinking data were
summarized for each participant at pre-treatment, at
weekly intervals for the 12 weeks of the trial, and at
monthly intervals during the follow-up. Drinking data
consisted of two measures, percent days abstinent (PDA)
and drinks per drinking day (DDD). Participants were
identified by which of the three treatments they received,
Cognitive Behavioral (CBT), Motivation Enhancement
(MET) or Twelve-Step (TSF). The number of treatment ses-
sions each participant attended was also included. It is
this variable that is the focus of this study.
The first step of the analysis was to compare our data to
official published results. Pearson correlations were com-
puted between number of treatment sessions attended
with percent days abstinent and with drinks per drinking
days at follow-up. We then computed correlations
between number of sessions and the drinking variables
during treatment. Both our analyses and previously pub-
lished MATCH analyses substituted transformed scores
for the drinking measures in order to normalize the data
and thereby meet the assumptions of the statistical tests.
The transformed scores were supplied in the data set. In
this study we used the transformed scores for all statistical
tests and the original drinking measures for display
purposes.
In the next step the participants were categorized into
groups based on the number of treatment sessions they
attended, ranging from 0 to 12. Those alcoholics who
signed up for the study but who never attended any ses-
sions were coded zero. Those who were coded 12 attended
every session and received either CBT or TSF but not MET.
MET consisted of only 4 sessions. The outcome variables
analyzed in this study are restricted to the two primary
MATCH outcome variables.
Three groups were formed consisting of participants who
attended either 0, 1 or all 12 treatment sessions. Chi
square tests were used to test relationships between cate-
gorical variables. Repeated measures Manovas were used
to test the differences between groups over all time points.
Drinking outcome at follow-up was a mean of the entire
follow-up period (from month 4 to month 15). The trans-
formed scores were used to compute effect size. Paired t-
tests were used to test for change within groups and inde-
pendent groups t-tests were used to test differences
between groups. Drinking data were incomplete for a
number of the participants in the 0 and 1 session treat-
ment groups. The highest level of missing data occurred at
week one, where data were available for 57% of the 0 ses-
sion group and 73% of the 1 session group. By follow-up,
data were available for about 80% of participants in both
these dropout groups.
Results
Table 2 compares our results to the Project MATCH's pub-
lished results [20] on the correlations between number of
treatment sessions attended (0 to 12, or 0 to 4 for MET)
and the two primary outcome measures, drinks per drink-
ing day and percent days abstinent. The table shows that
our results are essentially identical to the official results.
This indicates that the data used in the present study are
correct. Additionally the results show rather low correla-
tions between number of treatment sessions attended and
outcome, particularly long term outcome. The percent of
variance explained can be obtained by squaring the corre-
lation coefficient. The amount of outcome that can be
attributed to attending treatment ranges from 0 to 9%,
with a median of approximately 3%.
Table 3 displays the same type of correlations as in Table
2, but this time the drinking measures were for the weeks
during treatment. The table shows that there is a relation-
ship between drinking level at these early time points and
number of treatment sessions. Note that drinking level at
week one predicts the total number of weeks the partici-
pant will remain in treatment.
Tables 4 and 5 display the mean follow-up data for the
two primary drinking outcomes (percent days abstinent
and drinks per drinking day) of Project MATCH. Outcome
at follow-up is a mean of the data from 4 to 15 months.
Overall the data show that the three treatments were fairly
equal and that patients who attended more sessions had
somewhat better outcomes. However, there was one
anomalous group. Those who dropped out after one ses-
sion (the 1 treatment group) had worse outcomes than
those who dropped out before attending even one ses-
sion. They had worse scores than this zero treatment
group on 46 of 50 measures (percent days abstinent and
drinks per drinking day at pre-treatment, 12 weeks of
scheduled therapy, and 12 follow-up time points). All the
data are shown in the attached file [see Additional file 1].
They also had worse scores than the other treatment
groups (those who attended 2 to 12 sessions) on 526 of
550 measures. The one treatment group was significantly
worse that the zero treatment group over all time pointsBMC Public Health 2005, 5:75 http://www.biomedcentral.com/1471-2458/5/75
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for both percent days abstinent (F = 4.73 (1, 130) p =
.031) and drinks per drinking day (F = 4.51 (1, 130) p =
.036).
Next, in order to better illustrate what is happening in
these data, mean drinking levels of participants who
dropped out before receiving any treatment (N = 100 at
baseline) is compared to those who attended all 12 ses-
sions of Cognitive Behavioral or Twelve-Step Therapy (N
= 355 at baseline). Also included are the anomalous group
identified above, i.e., the group that dropped out after
attending only one treatment session (N = 121 at
baseline). We can dispense with displaying the results for
groups 2 through 11 without losing any information
Table 2: A comparison of our results to the results published by the official MATCH study group shows correlations between number 
of treatment sessions attended and drinking outcome.
Percent Days Abstinent
Our results Published MATCH results
Month CBT* MET TSF CBT MET TSF
6 .2556 .0269 .2678 .26 .03 .27
9 .1743 .0135 .2666 .17 .01 .27
12 .1685 .0011 .2657 .17 .00 .27
15 .1111 .0583 .2162 .11 .06 .22
Drinks per drinking day
Month CBT MET TSF CBT MET TSF
6 -.2281 -.0969 -.2832 -.22 -.10 -.28
9 -.2112 -.0856 -.2875 -.21 -.09 -.29
12 -.1372 -.0425 -.3028 -.14 -.04 -.30
15 -.1257 -.0795 -.2073 -.13 -.08 -.21
* CBT = Cognitive Behavioral Therapy
MET = Motivational Enhancement Therapy
TSF = Twelve Step Facilitation Therapy
Table 3: Correlations between number of treatment sessions attended and drinking during the course of the study.
Percent Days Abstinent Drinks Per Drinking Day
Week CBT* MET TSF CBT MET TSF
1 .207 .107 .278 -.232 -.150 -.251
2 .279 .131 .301 -.311 -.183 -.242
3 .302 .115 .373 -.340 -.152 -.309
4 .342 .108 .375 -.359 -.131 -.303
5 .356 .157 .407 -.361 -.183 -.344
6 .371 .165 .373 -.346 -.156 -.304
7 .354 .184 .391 -.358 -.209 -.346
8 .345 .181 .375 -.326 -.203 -.326
9 .352 .140 .397 -.339 -.175 -.375
10 .400 .149 .378 -.384 -.154 -.331
11 .399 .136 .418 -.432 -.156 -.395
12 .395 .121 .436 -.404 -.160 -.413
* CBT = Cognitive Behavioral Therapy
MET = Motivational Enhancement Therapy
TSF = Twelve Step Facilitation TherapyBMC Public Health 2005, 5:75 http://www.biomedcentral.com/1471-2458/5/75
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because of the linear relationship between number of
treatment sessions and drinking level shown in Tables 2
and 3. Scores for these other groups, who attended
between 2 and 11 treatment sessions, fell in a linear
manner between the 0 and the 12 session groups (as
shown in Tables 4 and 5 and the Additional File 1).
There was no relationship between membership in the
groups (0, 1 or 12) and inpatient or outpatient status (Chi
square = .06 (2) p = .966) or gender (Chi square = .43 (2)
p = .805). However there was a strong relationship with
treatment site (Chi square = 93.90 (20) p < .0001). Some
sites had larger number of participants dropping out
before treatment, some had larger numbers dropping out
after one treatment, and some had larger numbers attend-
ing the full 12 sessions. Some of this difference may have
been due to different procedures at different sites, some
may have been due to characteristics of the therapists or
participants.
Table 4: Percent days abstinent at follow-up.
Total Number of
Sessions Participant
Received Therapy
Cognitive
Behavioral
(CBT) %
Twelve-Step
Facilitation
(TSF) %
Motivation
Enhancement
(MET) %
Mean of All
0 .68 .69 .75 .72
1 .64 .61 .70 .64
2 .74 .69 .73 *
3 .68 .63 .72 *
4 .50 .76 .77 *
5. 7 9 . 6 9 . 7 2
6. 7 8 . 8 2 . 8 0
7. 7 3 . 7 2 . 7 3
8. 7 7 . 6 3 . 7 0
9. 7 7 . 7 8 . 7 8
10 .74 .86 .80
11 .83 .85 .84
12 .85 .87 .86
Note: Means were calculated for total sample available at follow-up.
* Not calculated since MET was restricted to 4 sessions
Table 5: Drinks per drinking day at follow-up.
Total Number of
Sessions Participant
Received Therapy
Cognitive
Behavioral
(CBT) %
Twelve-Step
Facilitation
(TSF) %
Motivation
Enhancement
(MET) %
Mean of All
0 6.54 7.42 7.71 7.32
1 8.22 8.66 5.98 7.84
2 6.03 6.55 6.91 *
3 9.25 7.37 5.96 *
4 7.74 4.78 4.71 *
5 3.78 6.62 5.65
6 7.30 4.19 5.51
7 5.90 6.50 6.19
8 4.70 6.00 5.35
9 5.04 5.69 5.40
10 6.14 3.72 4.95
11 4.50 2.97 3.78
12 3.23 3.18 3.21
Note: Means were calculated for total sample available at follow-up.
* Not calculated since MET was restricted to 4 sessionsBMC Public Health 2005, 5:75 http://www.biomedcentral.com/1471-2458/5/75
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Figures 1 and 2 show pre-treatment and follow-up out-
come data for the 0, 1 and 12 session groups. The figures
shows large improvements in percent days abstinent (Fig-
ure 1) and drinks per drinking day (Figure 2) for partici-
pants who attended either 0, 1 or all 12 treatment
sessions. The improvement in both measures is highly sig-
nificant for all groups (Table 6). Participants who received
either 0, 1 or 12 treatment sessions are displayed. Shown
are the raw score means and the statistical tests and effect
size estimates which were calculated using the Project
MATCH transformed scores. Participants in the 0 and 1
treatment session groups dropped out and received little
or no treatment.
The participants who dropped out after one session (the 1
session group) had worse scores than the other groups at
pre-treatment as well as follow-up on both measures.
Additionally, at baseline the 0 treatment group's scores
were noticeably worse than the 12 treatment group's
scores on drinks per drinking day (t = 3.26, 395 df, p =
.001).
Effect sizes for all groups are also shown in Table 6. For
percent days abstinence, those who dropped out before
receiving any treatment had an effect size of 1.50, and
those who attended all 12 sessions had an effect size of
2.04. For drinks per drinking day, there were effect sizes of
1.53 for the zero treatment group and 2.49 for the full
treatment group. The estimated no-treatment effect sizes
as proportions of the full treatment response was .73
(1.50/2.04) for percent days abstinent and .61 (1.53/
2.49) for drinks per drinking day.
Figures 3 and 4 show the data for the 12 weeks of the treat-
ment period. Improvement from pre-treatment to week 1
was statistically highly significant for all groups for both
measures (Table 6). The estimated no-treatment effect
sizes as proportions of the full treatment response was .85
(1.98/2.32) for percent days abstinent and .72 (2.10/
2.91) for drinks per drinking day. Only the 12 session
group showed significant improvement from week 1 to
week 12 (Table 6).
Change from week one to follow-up showed deterioration
for the zero and full treatment groups for both measures.
There were no significant differences between the zero
treatment dropout group and the full treatment group
from week 1 to follow up in percent days abstinent (t =
.25, 395 df, p = .800) or in drinks per drinking day (t =
1.22, 395 df, p = .222).
Discussion
The results suggest that treatment was not particularly
effective. The following lines of evidence point to this con-
clusion. Correlations between treatment attendance and
outcome were very small (as shown in Table 2). A median
Percent days abstinent at follow-up Figure 1
Percent days abstinent at follow-up. Percent days abstinent at 
pre-treatment and follow-up for patients who received 0, 1 
or 12 treatment sessions. The 0 treatment dropout group 
showed great improvement from pre-treatment to follow-
up. The 1 session attendance dropout group had worse 
scores than did the 0 treatment group. These data suggest 
that most of the improvement in the full 12 session attend-
ance group cannot be due to treatment. See also Figure 2.
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Drinks per drinking day at follow-up. Drinks per drinking day 
at pre-treatment and follow-up for patients who received 0, 
1 or 12 treatment sessions. The 0 treatment dropout group 
showed great improvement from pre-treatment to follow-
up. The 1 session attendance dropout group had worse 
scores than did the 0 treatment group. These data suggest 
that most of the improvement in the full 12 session attend-
ance group cannot be due to treatment. See also Figure 1.
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3% of the variance in outcome might be attributed to
treatment.
The correlations existed before most treatment occurred,
at week 1 (Table 3). We would normally infer from the
correlations in Table 2 that more treatment produces bet-
ter drinking outcomes, but the Table 3 correlations sug-
gests the reverse, that better drinking levels predict more
treatment.
Table 6: Change in primary outcomes for various periods of the study for participants who dropped out early (0 or 1 week) and for 
those who received full treatment (12 weeks).
Total Improvement
Percent days abstinent
Group Pretreatment Follow-up t= df p= Effect
0 3 3 7 21 . 9 58 5. 0 0 0 1 . 4 9 8
1 29 64 9.30 105 .000 1.320
12 30 86 31.74 354 .000 2.042
Drinks per drinking day
0 17.9 7.3 1.75 85 .000 1.534
1 22.8 7.6 11.99 105 .000 1.552
12 15.7 3.2 34.68 354 .000 2.494
Instantaneous Improvement (week 1)
Percent days abstinent
Group Pretreatment Week 1 t= df p= Effect
0 3 2 8 19 . 1 75 6. 0 0 0 1 . 9 8 1
1 3 0 6 98 . 4 38 7. 0 0 0 1 . 4 4 7
12 30 92 35.30 339 .000 2.317
Drinks per drinking day
0 18.7 3.8 1.75 56 .000 2.097
1 22.5 8.7 9.69 87 .000 1.770
12 15.6 1.5 35.28 339 .000 2.909
Acute Treatment Phase (weeks 1 & 12)
Percent days abstinent
Group Week 1 Week 12 t= df p= Effect
0 81 81 .19 56 .852 -.025
1 6 9 6 31 . 6 98 7. 0 9 8 - . 1 7 4
12 92 96 2.82 339 .005 .155
Drinks per drinking day
0 3.8 5.0 1.08 56 .283 -.172
1 8.7 8.8 .82 87 .415 -.090
12 1.5 1.1 2.05 339 .041 .126BMC Public Health 2005, 5:75 http://www.biomedcentral.com/1471-2458/5/75
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Nearly two thirds of the long term improvement in the
full treatment group was matched by the untreated rapid
dropout group (Figures 1 &2 and Table 6). Only in the
remaining one third could there be a subcomponent con-
sisting of a treatment effect.
Most of the improvement was instantaneous, occurring at
week 1, before the participants had received the bulk of
their treatment (Figures 3 &4 and Table 6). Although the
full treatment group received 11 more therapy sessions,
the additional improvement was of small magnitude. For
example, at week one percent days abstinence had
increased by over 60%, and the additional 11 weeks of
treatment increased it by only 4%. If treatment were the
causal agent we would expect that the effect would occur
over the course of weeks with the administration of
treatment.
There was a similar instantaneous improvement in
untreated alcoholics (Figures 3 &4 and Table 6). The effect
size estimates suggested that nearly three fourths of the
instantaneous improvement in the full treatment group
was matched by the untreated group.
Those who received zero treatment sessions had better
outcomes than those who received one session (Figures 1
to 4 and Tables 4 to 6). The implication of this is discussed
below.
Improvement was maintained over time even in the no
treatment group (Figures 1 to 4 and Table 6). Change
from week 1 to follow-up was not significantly different
between the zero and full treatment groups. In both
groups the week 1 to week 12 improvement was lost by
follow-up. These data do not support the contention that
retention of clients in treatment for as long as possible
increases the chances that they will derive benefit from
therapy.
A more reasonable interpretation of these data is that they
illustrate the importance of selection effects, i.e., partici-
pants who reduce their alcohol consumption are more
likely to enter or remain in treatment and those who
continue drinking are more likely to drop out of treat-
ment. One of the best studies of alcoholism treatment
outcome was conducted by the Rand Corporation in the
late 1970s [10]. Participants were patients who attended
inpatient or outpatient treatment at centers across the
United States. They found that "it is possible that the cor-
relation [between attendance and outcome] arises from
selection effects, such that the better motivated or more
successful patients continue in treatment, whereas the
more intractable cases drop out. Such a pattern could
result from subject self-selection or from the operation of
the treatment environment in encouraging continued
Percent days abstinent during treatment Figure 3
Percent days abstinent during treatment. Percent days absti-
nent at pre-treatment and during the 12 weeks of treatment 
for patients who received 0, 1 or 12 treatment sessions. The 
effective improvement in drinking was instantaneous, evident 
at week 1. The improvement was maintained at the same 
approximate level for the 12 weeks of scheduled treatment. 
The effect occurred for all groups, whether they attended all 
12 treatment sessions, only one treatment session, or did 
not attend any treatment sessions. See also Figure 4.
Drinks per drinking day during treatment Figure 4
Drinks per drinking day during treatment. Drinks per drink-
ing day at pre-treatment and during the 12 weeks of treat-
ment for patients who received 0, 1 or 12 treatment 
sessions. The effective improvement in drinking was instanta-
neous, evident at week 1. The improvement was maintained 
at the same approximate level for the 12 weeks of scheduled 
treatment. The effect occurred for all groups, whether they 
attended all 12 treatment sessions, only one treatment ses-
sion, or did not attend any treatment sessions. See also Fig-
ure 3.
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participation for more responsive patients." (page 155).
The likely selection effect in the current data was illus-
trated by the anomalous group participants who dropped
out after attending only one treatment session as shown
in Figures 1 and 2. Those who received zero treatment had
better outcomes than those who received one session of
treatment. Few would argue that this shows that treatment
was harmful. A more likely explanation for this difference
is some sort of self-selection. The higher drinking level of
the 1 session dropout participants at baseline suggests that
they may have been more dependent on alcohol than
those in the 0 session dropout group. The relative higher
level of dependence may have put these individuals under
more pressure to do something about their drinking,
explaining why they did not drop out prior to the first ses-
sion. A similar logic could apply to the outcomes of the
consistent attendees of the full treatment group. The likely
selection effect is also shown in that participants with
higher drinking levels at week 1 were more likely to drop
out of treatment (Table 3).
The decreased drinking in both untreated and treated par-
ticipants can be explained by a number of factors. One
factor is that part of the effect is not real; many active alco-
holics underreport drinking. Collateral informant inter-
views and other verification techniques are only partially
effective in correcting the data. The Rand study [10], for
example, found that 30% of the collateral informants
were unable to provide information. Underreporting can
make treatment appear more effective than it actually is.
Additionally, there are a number of non-treatment effects
likely to result in reduced drinking [19,21-23]. In order to
enter the trial participants had to first achieve a level of
abstinence or reduced intake. If a participant arrives at a
site in an intoxicated state immediate action is required by
staff, such as admission to a detox unit, or detainment in
the waiting room until the breath alcohol level returns to
normal. These rules would have applied to each
participant in Project MATCH at the time of enrollment
and would have contributed to the rapid improvement
seen in the week one data. The pre-study screening proce-
dures used in clinical trials, both the overt criteria and the
subjective criteria, are designed to select participants who
are motivated to reduce their drinking. Enrolling in the
trial suggests that the alcoholic has crystallized a decision
to reduce or abstain from drinking. Once in the trial, the
continued monitoring of drinking behavior by staff per-
sonnel may have both motivational and therapeutic
benefits. For example, in one study with a 2 year follow-
up [21], over half the participants indicated they liked the
"caring, concern and help" follow-up telephone contact,
and in another [24], the telephone interviewers reported
that they usually entered in a sympathetic interaction with
the study participants. Such positive empathetic contact
could be of therapeutic benefit.
There are a number of limitations to these analyses. The
data from two thirds of the subjects were not used in the
illustration of mean drinking levels shown in the figures
and in Table 6. However these data were used in Tables 2
though 5, and are presented in more detail in the attached
data [see Additional File 1]. The linear relationship shown
in Tables 2 and 3, and the means in Tables 4 and 5 indi-
cated that no information was left out. Additionally, other
analyses of these groups have been previously published,
e.g., by the Project MATCH research group [20]. We chose
to highlight several specific groups. The logic of selecting
the group that received no treatment and the group that
received all 12 sessions of treatment was clear – they
offered an unambiguous treatment comparison. The data
presented here show that the outcomes of the 12 session
group were better than the outcomes of participants who
received between 2 and 11 sessions, making the 12 ses-
sion group a fair comparison. Additionally we identified
an anomalous group, the one session rapid dropouts, and
used that group in an attempt to interpret the data. The
mathematical bases for the anomalous designation, and
thus the selection of this group, were presented.
Analyses were primarily limited to descriptive and simple
inferential statistics. This was done because the findings
are likely to be extremely controversial. We have therefore
presented results that are easily replicated, and easily
understood.
Although the results are essentially negative, suggesting
that current treatments are not effective, we do not offer
suggestions for future directions. We feel we will have
made a contribution if the data presented can be accepted
as accurate. If they are accepted then implications for
future research and treatment will naturally follow. For
example, if the patient's motivations, opportunities,
beliefs and hopes are the critical issues, how do we
measure them? How do we influence them? How do they
interact with the treatment environment?
It may be that pre-treatment patient characteristics (e.g.,
level of dependence, social support, etc.) have a large
influence on both the number of treatment sessions
attended and drinking outcome. However, even if this is
true, it would not be evidence of treatment effectiveness.
Only if one could show that positive prognostic factors
were weighted heavily against the treatment attendees and
in favor of the dropouts would these results be open to
reinterpretation. The baseline and week one drinking data
presented here do not support the likelihood of such a
possibility. Additionally, there is no evidence in the
literature to support the notion that, for example,BMC Public Health 2005, 5:75 http://www.biomedcentral.com/1471-2458/5/75
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alcoholics who lack social support are more likely to enter
or remain in treatment. There are a large number of both
positive and negative reasons why alcoholic participants
drop out of clinical trials. Positive reasons include work
commitments, pregnancy, re-location to another area and
remission from drinking. Negative reasons include
continued or increased drinking, abuse of other sub-
stances, attitude towards the clinical staff or environment,
physical illness, hospitalization and incarceration.
Conclusions drawn from therapy delivered in clinical tri-
als might not be applicable to therapy in other settings.
We might well expect great differences in clinical effective-
ness between different therapists, and between different
treatment programs. However it can be argued that the
large non-treatment effect seen in this study is present in
other aggregated outcome studies published in the litera-
tures. Miller and others [9] presented results from a
number of such trials, in addition to Project MATCH.
Table 1 summarized their findings for the two outcome
variables studied here. The outcomes of the different stud-
ies are remarkably similar. The similarity in results would
suggest that the non-treatment effect identified here may
be present in all these studies.
The outcome variables in these analyses were the original
primary MATCH outcome variables. We have been able to
show that the analyses of these variables, and the treat-
ment attendance variable, are in perfect concordance with
published analyses of the Project MATCH Research group
[20]. Over 60 publications have been generated by Project
MATCH, but, to the best of our knowledge, all have over-
looked the main finding of this study, i.e., the good out-
comes of the zero treatment group when compared to the
full treatment group and that the improvement in all
groups occurred immediately after enrollment in the trial.
Ineffective treatment would be the most parsimonious
explanation for the rather surprising main findings of
Project MATCH, that there was no match between patient
characteristics and different types of treatment, and that
all three treatments were equal.
There may be similarities between these results, for alco-
holism patients, and effects seen in some other types of
patients. Depressed patients sometimes report significant
improvement after enrolling in clinical trials but before
receiving therapy [25]. Recent time-course analyses in
depression report sudden decreases in depression regard-
less of treatment condition [26]. These rapid responders
were associated with better outcome at the end of the
treatment and into follow-up [27].
It is difficult to compare the high quality follow-up data
of Project MATCH to that in the alcoholism literature,
much of which are collected under quite different circum-
stances. The zero treatment participants at the final fol-
low-up interval (month 15) reported a mean of 25.1
drinks per week, with 45% (35/78) abstinent. These
outcomes appear somewhat better than those recently
summarized in the literature [17]. Of some 17 studies
than included placebo or no treatment conditions, with
and without prior detoxification, a mean (for studies) was
21% abstinent, and the average participant was drinking
31 drinks per week [17].
Exaggerated claims of treatment effectiveness can have
undesirable consequences for patients, for therapists, and
for science. Patients who fail an "effective" treatment may
feel even more hopeless. This increased despair may be
extremely deleterious in people with such life-threatening
habits. Therapists may feel inadequate or frustrated with
repeated failures. For science, exaggerated claims tend to
shift focus into unproductive directions, and to obscure
the pertinent facts that are necessary in order to move the
science forward.
While this study shows that three of the best treatments
currently available for addiction were not very effective, it
remains likely that many severely dependent alcoholic
individuals benefit from external help. By suggesting
practical and helpful ways for dealing with the problems
of addiction, therapy may help a patient regain a sense of
control over his or her life. We are not suggesting that
alcoholism treatment should be discontinued or even
reduced. People with alcohol problems clearly need all
the help our society can give them.
Conclusion
These results suggest that current psychosocial treatments
for alcoholism are not particularly effective. The
improvements in drinking appear to be due to selection
effects. Alcoholics who decide to enter treatment are likely
to reduce drinking. Those who decrease their drinking are
more likely to remain in treatment. Widespread accept-
ance of these results would have a profound influence on
alcoholism research and treatment because it would shift
focus away from treatment components and toward
patient characteristics and beliefs.
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